Steris (STE) Income from Continuing Operations (2018 - 2026)
Steris' (STE) quarterly Income from Continuing Operations came in at 220300000.0 in Q1 2026, up 50.07% year-on-year from 146800000.0 in Q1 2025, and up 13.38% quarter-over-quarter from 194300000.0 in Q4 2025.
Steris (STE) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Steris' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 220300000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 50.07% year-over-year to 220300000.0 in Q1 2026; TTM through Mar 2026 was 785100000.0, a 28.41% increase from a year earlier, with the FY2026 full-year figure at 785100000.0, up 28.39% from the prior year.
- Income from Continuing Operations rose to 220300000.0 in Q1 2026 per STE's latest filing, from 194300000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 220300000.0 in Q1 2026 and bottomed at 93642000.0 in Q1 2022.
- The 5-year median for Income from Continuing Operations is 148603000.0 (2023), against an average of 152918764.71.
- Across the five-year window, Income from Continuing Operations surged 643.72% in 2022 and slipped 15.86% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 131005000.0 in 2022, then climbed by 13.43% to 148603000.0 in 2023, then gained by 16.62% to 173300000.0 in 2024, then increased by 12.12% to 194300000.0 in 2025, then grew by 13.38% to 220300000.0 in 2026.
- Per Business Quant, the three latest STE Income from Continuing Operations figures stand at 220300000.0 (Q1 2026), 194300000.0 (Q4 2025), and 192500000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 220.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220.30 Mn |
| Dec 31, 2025 | 194.30 Mn |
| Sep 30, 2025 | 192.50 Mn |
| Jun 30, 2025 | 178.00 Mn |
| Mar 31, 2025 | 146.80 Mn |
| Dec 31, 2024 | 173.30 Mn |
| Sep 30, 2024 | 151.40 Mn |
| Jun 30, 2024 | 139.90 Mn |
| Mar 31, 2024 | 153.30 Mn |
| Dec 31, 2023 | 148.60 Mn |
| Sep 30, 2023 | 120.80 Mn |
| Jun 30, 2023 | 130.58 Mn |
| Mar 31, 2023 | 182.20 Mn |
| Dec 31, 2022 | 131.01 Mn |
| Sep 30, 2022 | 123.91 Mn |
| Jun 30, 2022 | 119.09 Mn |
| Mar 31, 2022 | 93.64 Mn |
| Dec 31, 2021 | 143.09 Mn |
| Sep 30, 2021 | 69.63 Mn |
| Jun 30, 2021 | -21.90 Mn |